Ensuring raw material quality - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Ensuring raw material quality


Pharmaceutical Technology Europe



Sheelagh Halsey
Nearinfrared (NIR) spectroscopy is a wellknown tool for identifying raw materials in the pharmaceutical industry. It is a very sensitive, nondestructive technique using overtones and combination bands of fundamental vibrations derived from the mid-infrared. Spectra can be used to distinguish closely related materials such as API polymorphs and excipient analogues. Analysis time is only a few seconds and samples can be analysed in disposable glass vials or directly with a fibre optic probe.

However, NIR spectroscopy can be used for more than just raw material identification. With current industry trends using PAT and Quality by Design (QbD) initiatives, building knowledge and reducing risk in production processes are becoming increasingly important. Many companies are focusing research on unit operations such as blending and tableting, but there is much to be gained by revisiting the quality of raw materials entering the process.


Figure 1: NIR spectra of lactose polymorphs.
Raw materials can now be identified and tested for manufacturing suitability. Most unit operations are physical processes. Physical properties of raw materials affect the manufacturing process when used in an inflexible recipe, resulting in poor quality products. Changes in particle size or polymorphism will influence flow properties and moisture uptake, which in turn affect blend and compression behaviour. The result could be poor content uniformity. NIR spectra are sensitive to these physical changes, as well as chemical identification. Figure 1 shows NIR spectra of lactose polymorphs generated using an FT-NIR analyser (Antaris II; Thermo Scientific, UK). These spectra show that the hydrated form has a marked peak at around 5150 cm-1 (1940 nm), indicating chemical sensitivity to water. The spectra also demonstrate the sensitivity of the technique to morphology changes. The amorphous form shows fewer features than the crystalline form. For example, many sharp peaks can be seen in the 4000–4500 cm–1 (2200–2500 nm) region in the crystalline forms, whereas the amorphous form shows little detail. These spectral changes allow the material to be identified as lactose, but also to be qualified as the correct morphology required for a particular process.


Figure 2: NIR spectra of cellulose of different particles.
Figure 2 shows the NIR spectra of microcrystalline cellulose of three different particle sizes. Reflectance spectra exhibit baseline shifts because of different light scattering from the samples. This leads to larger particle size samples having a higher baseline than smaller particle sizes. Hence, the 180-μ cellulose sample has a higher absorbance than the 50-μ sample. Furthermore, the reflectance and scattering is not constant across the whole NIR spectrum. Shorter wavelengths (higher frequency) light penetrates more and scatters less than longer wavelength (lower frequency) light. This gives rise to larger baseline shifts at shorter wavenumbers (longer wavelengths) than at higher wavenumbers (shorter wavelengths). A more comprehensive explanation of diffuse reflectance theory can be found in reference 1.


ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
When sourcing raw materials and non-GMP intermediates or other chemicals, where are the majority of your suppliers located?
In the United States
In Western Europe
In Central and Eastern Europe
In Japan
In India
In China
In the United States
20%
In Western Europe
18%
In Central and Eastern Europe
4%
In Japan
2%
In India
27%
In China
29%
View Results
Eric LangerOutsourcing OutlookEric Langer A Bio View of Outsourcing
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advances in Custom Synthesis
Faiz kermaniSpotlightFaiz Kermani Reinvigorating European R&D innovation
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
PhRMA Details Its Proposal for Internet and Social-Media Standards
The Unregulated Regulator
Rx-360 Goals Get off the Ground
US and Europe At Risk from Substandard Medicines
What is Next in Patent Reform?
FindPharma Custom Search
Source: Pharmaceutical Technology Europe,
Click here